Autopsy report · NCT02054338

A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast Cancer

“Study was stopped before progressive disease or death of alive subjects.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 7 years 8 months after it had already started.
• Ran for about 8 years 8 months before it stopped.
• 1,004 participants enrolled.
• Results were posted on the registry 4 years 6 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Pierre Fabre Medicament

Sponsor type

Industry

Conditions

Advanced Breast Cancer

Interventions

Vinflunine+Gemcitabine; Paclitaxel+Gemcitabine

Participants

1,004

Trials that died the same way

• Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery
  “The study was stopped due to difficulties in including patients” (72% match in meaning)
• TTAX03 for the Treatment of Lumbosacral Facet Joint Pain
  “Study was stopped due to reprioritization for active studies” (71% match in meaning)
• Comparison of Efficacy of Behavioral Approaches for Treatment of Insomnia
  “Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention. COVID Complications.” (69% match in meaning)
• A Study of PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving Chemotherapy
  “Study stopped as it would not address important survival concerns raised in other recently conducted clinical studies.” (69% match in meaning)
• A Comparison of Surgical Preparations and Wound Infection Rates for Elective Cesarean Sections
  “Study was stopped following interim analysis.” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.